NVS logo

Novartis AG (NVS) Non Current Assets

Annual Non Current Assets

$69.46 B
-$11.08 B-13.76%

31 December 2023

NVS Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$72.26 B
+$448.00 M+0.62%

30 September 2024

NVS Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVS Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.8%+7.8%
3 y3 years-29.2%-23.9%
5 y5 years-36.9%-19.1%

NVS Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-29.2%at low-23.9%+7.8%
5 y5 years-36.9%at low-28.3%+7.8%
alltimeall time-36.9%+343.9%-34.7%+365.7%

Novartis AG Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$72.26 B(+0.6%)
June 2024
-
$71.81 B(+5.8%)
Mar 2024
-
$67.89 B(-2.3%)
Dec 2023
$30.48 B(-17.4%)
$69.46 B(+3.6%)
Sept 2023
-
$67.04 B(-13.5%)
June 2023
-
$77.49 B(-3.3%)
Mar 2023
-
$80.13 B(-0.5%)
Dec 2022
$36.91 B(-19.3%)
$80.54 B(-1.2%)
Sept 2022
-
$81.51 B(-3.8%)
June 2022
-
$84.77 B(-3.7%)
Mar 2022
-
$87.98 B(+2.2%)
Dec 2021
$45.72 B(+54.1%)
$86.08 B(-9.4%)
Sept 2021
-
$94.96 B(-5.2%)
June 2021
-
$100.21 B(+0.7%)
Mar 2021
-
$99.55 B(+1.5%)
Dec 2020
$29.67 B(+0.6%)
$98.11 B(-2.6%)
Sept 2020
-
$100.70 B(+0.8%)
June 2020
-
$99.88 B(-0.1%)
Mar 2020
-
$100.00 B(+12.5%)
Dec 2019
$29.50 B(-17.0%)
$88.87 B(-0.5%)
Sept 2019
-
$89.30 B(+1.5%)
June 2019
-
$87.97 B(+2.9%)
Mar 2019
-
$85.50 B(-22.3%)
Dec 2018
$35.56 B(+26.1%)
$110.00 B(+1.0%)
Sept 2018
-
$108.88 B(-1.0%)
June 2018
-
$109.99 B(+7.3%)
Mar 2018
-
$102.47 B(-2.3%)
Dec 2017
$28.21 B(+13.1%)
$104.87 B(-2.5%)
Sept 2017
-
$107.51 B(+0.3%)
June 2017
-
$107.21 B(+0.9%)
Mar 2017
-
$106.22 B(+1.0%)
Dec 2016
$24.93 B(+9.1%)
$105.19 B(-2.7%)
Sept 2016
-
$108.12 B(+0.4%)
June 2016
-
$107.71 B(-1.6%)
Mar 2016
-
$109.45 B(+0.7%)
Dec 2015
$22.84 B(-39.2%)
$108.71 B(-0.2%)
Sept 2015
-
$108.88 B(-1.6%)
June 2015
-
$110.67 B(+1.3%)
Mar 2015
-
$109.22 B(+24.4%)
Dec 2014
$37.56 B(+23.0%)
$87.83 B(-0.9%)
Sept 2014
-
$88.59 B(-2.4%)
June 2014
-
$90.80 B(-5.1%)
Mar 2014
-
$95.64 B(-0.1%)
Dec 2013
$30.54 B(+9.1%)
$95.71 B(-0.1%)
Sept 2013
-
$95.82 B(+1.7%)
June 2013
-
$94.23 B(+0.0%)
Mar 2013
-
$94.22 B(-2.0%)
Dec 2012
$28.00 B
$96.19 B(+1.2%)
DateAnnualQuarterly
Sept 2012
-
$95.07 B(+2.9%)
June 2012
-
$92.37 B(-1.3%)
Mar 2012
-
$93.62 B(+0.2%)
Dec 2011
$24.08 B(-9.7%)
$93.41 B(-2.5%)
Sept 2011
-
$95.81 B(-3.5%)
June 2011
-
$99.29 B(+1.2%)
Mar 2011
-
$98.12 B(+1.5%)
Dec 2010
$26.68 B(-20.8%)
$96.63 B(-0.3%)
Sept 2010
-
$96.91 B(+66.4%)
June 2010
-
$58.26 B(-2.9%)
Mar 2010
-
$59.99 B(-2.9%)
Dec 2009
$33.69 B(+61.3%)
$61.81 B(+2.6%)
Sept 2009
-
$60.25 B(+5.5%)
June 2009
-
$57.10 B(+2.9%)
Mar 2009
-
$55.49 B(-3.4%)
Dec 2008
$20.88 B(-23.9%)
$57.42 B(-2.2%)
Sept 2008
-
$58.72 B(+14.4%)
June 2008
-
$51.31 B(+2.6%)
Mar 2008
-
$50.03 B(+4.2%)
Dec 2007
$27.43 B(+28.2%)
$48.02 B(-0.5%)
Sept 2007
-
$48.25 B(-3.5%)
June 2007
-
$49.98 B(+6.4%)
Mar 2007
-
$46.99 B(+0.8%)
Dec 2006
$21.40 B(-0.2%)
$46.60 B(+1.6%)
Sept 2006
-
$45.89 B(-0.5%)
June 2006
-
$46.13 B(+24.9%)
Mar 2006
-
$36.93 B(+1.8%)
Dec 2005
$21.44 B(-10.4%)
$36.29 B(+0.3%)
Sept 2005
-
$36.19 B(+9.9%)
June 2005
-
$32.93 B(+20.3%)
Mar 2005
-
$27.38 B(-4.1%)
Dec 2004
$23.92 B(+7.4%)
$28.57 B(+2.1%)
Sept 2004
-
$27.98 B(+3.6%)
June 2004
-
$27.00 B(-0.2%)
Mar 2004
-
$27.06 B(+0.1%)
Dec 2003
$22.27 B(+7.0%)
$27.04 B(+4.8%)
Sept 2003
-
$25.81 B(+1.3%)
June 2003
-
$25.48 B(+2.8%)
Mar 2003
-
$24.78 B(+2.4%)
Dec 2002
$20.82 B(+0.8%)
$24.21 B(+5.3%)
Sept 2002
-
$22.99 B(+3.0%)
June 2002
-
$22.32 B(+13.5%)
Dec 2001
$20.64 B(+1.1%)
$19.66 B(+4.3%)
June 2001
-
$18.86 B(+20.5%)
Dec 2000
$20.41 B(-6.3%)
$15.65 B(+0.9%)
June 2000
-
$15.52 B
Dec 1999
$21.77 B(+0.0%)
-
Dec 1998
$21.77 B
-

FAQ

  • What is Novartis AG annual long term assets?
  • What is the all time high annual non current assets for Novartis AG?
  • What is Novartis AG annual non current assets year-on-year change?
  • What is Novartis AG quarterly long term assets?
  • What is the all time high quarterly non current assets for Novartis AG?
  • What is Novartis AG quarterly non current assets year-on-year change?

What is Novartis AG annual long term assets?

The current annual non current assets of NVS is $69.46 B

What is the all time high annual non current assets for Novartis AG?

Novartis AG all-time high annual long term assets is $110.00 B

What is Novartis AG annual non current assets year-on-year change?

Over the past year, NVS annual long term assets has changed by -$11.08 B (-13.76%)

What is Novartis AG quarterly long term assets?

The current quarterly non current assets of NVS is $72.26 B

What is the all time high quarterly non current assets for Novartis AG?

Novartis AG all-time high quarterly long term assets is $110.67 B

What is Novartis AG quarterly non current assets year-on-year change?

Over the past year, NVS quarterly long term assets has changed by +$5.22 B (+7.79%)